Skip to main content
Clinical Trials/NCT05877287
NCT05877287
Completed
N/A

The Effect of Mındfulness-Based Stress Reductıon Program Applıed to Parents Wıth A Chıld Wıth Autısm on The Level Of Depressıon, Anxıety, Stress and Hopelessness: Randomızed Controlled Trıal

Necmettin Erbakan University1 site in 1 country96 target enrollmentJune 1, 2023

Overview

Phase
N/A
Intervention
mindfulness-based stress reduction program
Conditions
DEPRESSION
Sponsor
Necmettin Erbakan University
Enrollment
96
Locations
1
Primary Endpoint
Depression, Anxiety and Stress Scale (DASS-21)
Status
Completed
Last Updated
2 months ago

Overview

Brief Summary

This research was planned to examine the effect of mindfulness-based stress reduction program applied to parents with autistic children on the level of depression, anxiety, stress and hopelessness.

Detailed Description

The program applied to parents with children with autism will be carried out once a week for 60 minutes, for 8 weeks, in 8 sessions in total. The program will be conducted in face-to-face groups. Sessions will be held in a suitable area in the practice area. In each 60-minute session, it is planned to be 20 minutes of narration on the subject of the session, accompanied by a power point presentation, and the remaining 40 minutes of exercise, meditation practices and sharing experiences. In the table indicating the general operation of the sessions within the scope of the research; The purpose, target, teaching method, material place, time, session content and application steps of each session will be given to the participants. Awareness-Based Stress Reduction Program Applied to Parents with Children with Autism will be given to the participants in the first week, including the important points of the program, prepared by the researchers, and expert opinions will be taken.

Registry
clinicaltrials.gov
Start Date
June 1, 2023
End Date
September 25, 2025
Last Updated
2 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Selverhan Yurttutan

RESEARCH ASSISTANT

Necmettin Erbakan University

Eligibility Criteria

Inclusion Criteria

  • Being a parent of a child with autism
  • Being literate and able to communicate in Turkish

Exclusion Criteria

  • Having a diagnosed mental and mental health problem
  • Having a chronic, mental and mental health problem other than autism in a child with autism
  • Having previously participated in a mindfulness-based stress reduction program
  • Having another disabled child

Arms & Interventions

mindfulness-based stress reduction program

The FTSA program will be carried out once a week for 60 minutes, for 8 weeks, in a total of 8 sessions. The program will be conducted in face-to-face groups. Sessions will be held in a suitable area in the practice area. In each 60-minute session, it is planned to be 20 minutes of narration on the subject of the session, accompanied by a power point presentation, and the remaining 40 minutes of exercise, meditation practices and sharing experiences.

Intervention: mindfulness-based stress reduction program

control group

No application will be made.

Outcomes

Primary Outcomes

Depression, Anxiety and Stress Scale (DASS-21)

Time Frame: Third assessment will take place average 4 weeks after the second assessment.

The scale consists of 21 items and three sub-dimensions. Each of the seven items that make up each sub-dimension of the scale measures depression, anxiety and stress. The DASS-21 scale is a four-point Likert-type scale and the items are evaluated between 0 and 3 (0 = not at all suitable for me, 1 = somewhat appropriate for me, 2 = usually suitable for me, 3 = completely suitable for me). There is no reverse item in the scale. The total scores of the scale range from 0 to 21 for each sub-dimension. In the validity and reliability study, the Cronbach-alpha coefficient was determined as 0.87 for the depression sub-dimension, 0.85 for the anxiety sub-dimension, and 0.81 for the stress sub-dimension. The Cronbach-alpha coefficient for the Turkish version of the Depression, Anxiety and Stress scale was determined as 0.88 for the depression sub-dimension, 0.80 for the anxiety sub-dimension and 0.87 for the stress sub-dimension (Sarıçam, 2018).

Depression, Anxiety and Stress Scale (DASS-21)

Time Frame: First assessment will be made at the baseline (pre-intervention)

The scale consists of 21 items and three sub-dimensions. Each of the seven items that make up each sub-dimension of the scale measures depression, anxiety and stress. The DASS-21 scale is a four-point Likert-type scale and the items are evaluated between 0 and 3 (0 = not at all suitable for me, 1 = somewhat appropriate for me, 2 = usually suitable for me, 3 = completely suitable for me). There is no reverse item in the scale. The total scores of the scale range from 0 to 21 for each sub-dimension. In the validity and reliability study, the Cronbach-alpha coefficient was determined as 0.87 for the depression sub-dimension, 0.85 for the anxiety sub-dimension, and 0.81 for the stress sub-dimension. The Cronbach-alpha coefficient for the Turkish version of the Depression, Anxiety and Stress scale was determined as 0.88 for the depression sub-dimension, 0.80 for the anxiety sub-dimension and 0.87 for the stress sub-dimension (Sarıçam, 2018).

Depression, Anxiety and Stress Scale (DASS-21)

Time Frame: The second assessment will take place 8 weeks after the first assessment (after the program is completed).

The scale consists of 21 items and three sub-dimensions. Each of the seven items that make up each sub-dimension of the scale measures depression, anxiety and stress. The DASS-21 scale is a four-point Likert-type scale and the items are evaluated between 0 and 3 (0 = not at all suitable for me, 1 = somewhat appropriate for me, 2 = usually suitable for me, 3 = completely suitable for me). There is no reverse item in the scale. The total scores of the scale range from 0 to 21 for each sub-dimension. In the validity and reliability study, the Cronbach-alpha coefficient was determined as 0.87 for the depression sub-dimension, 0.85 for the anxiety sub-dimension, and 0.81 for the stress sub-dimension. The Cronbach-alpha coefficient for the Turkish version of the Depression, Anxiety and Stress scale was determined as 0.88 for the depression sub-dimension, 0.80 for the anxiety sub-dimension and 0.87 for the stress sub-dimension (Sarıçam, 2018).

Secondary Outcomes

  • Beck Hopelessness Scale (BUS)(Third assessment will take place average 4 weeks after the second assessment.)
  • Beck Hopelessness Scale (BUS)(First assessment will be made at the baseline (pre-intervention))
  • Beck Hopelessness Scale (BUS)(The second assessment will take place 8 weeks after the first assessment (after the program is completed).)

Study Sites (1)

Loading locations...

Similar Trials